1,7-phenanthroline has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S; Kwon, Y; Lee, SK; Song, J | 1 |
| Hiwada, K; Kokubu, T | 1 |
2 other study(ies) available for 1,7-phenanthroline and Kidney Neoplasms
| Article | Year |
|---|---|
Antitumor activity of phenanthroindolizidine alkaloids is associated with negative regulation of Met endosomal signaling in renal cancer cells.
Topics: Alkaloids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Endocytosis; Endosomes; Humans; Indoles; Indolizines; Kidney Neoplasms; Microscopy, Confocal; Phenanthrolines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-cbl; Proto-Oncogene Proteins c-met; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Stereoisomerism | 2015 |
Comparison of soluble and membrane-bound neutral arylamidases from renal cell carcinoma.
Topics: Adenocarcinoma; Aminopeptidases; Cell Membrane; Cobalt; Cytosol; Humans; Hydrogen-Ion Concentration; Kidney Neoplasms; Kinetics; Molecular Weight; Phenanthrolines | 1977 |